Report Detail
Global 3D Bioprinting for Tissue and Organ Regeneration Market Growth (Status and Outlook) 2022-2028
- RnM4398796 |
- 15 March, 2022 |
- Global |
- 111 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of 3D Bioprinting for Tissue and Organ Regeneration will have significant change from previous year. According to our (LP Information) latest study, the global 3D Bioprinting for Tissue and Organ Regeneration market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global 3D Bioprinting for Tissue and Organ Regeneration market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States 3D Bioprinting for Tissue and Organ Regeneration market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global 3D Bioprinting for Tissue and Organ Regeneration market, reaching US$ million by the year 2028. As for the Europe 3D Bioprinting for Tissue and Organ Regeneration landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main 3D Bioprinting for Tissue and Organ Regeneration players cover BIOLIFE4D, Organovo, Celllink, and Aspect Biosystems, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of 3D Bioprinting for Tissue and Organ Regeneration market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Clinical Applications
Research Applications
Drug and Medical Research
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
BIOLIFE4D
Organovo
Celllink
Aspect Biosystems
Cyfuse Biomedical
TeVido Biodevices
Digilab
Advanced Solutions Life Sciences
TRS – Tissue Regeneration Systems
Nscrypt, Inc
EnvisionTEC
MedPrin
Nano3D Sciences
Rokit
Cellbricks
REGEMAT 3D
Allevi
Poietis
T&R BIOFAB
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global 3D Bioprinting for Tissue and Organ Regeneration Market Size 2017-2028
- 2.1.2 3D Bioprinting for Tissue and Organ Regeneration Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 3D Bioprinting for Tissue and Organ Regeneration Segment by Type
- 2.2.1 Magnetic 3D Bioprinting
- 2.2.2 Laser-assisted Bioprinting
- 2.2.3 Inkjet 3D Bioprinting
- 2.2.4 Microextrusion 3D Bioprinting
- 2.3 3D Bioprinting for Tissue and Organ Regeneration Market Size by Type
- 2.3.1 3D Bioprinting for Tissue and Organ Regeneration Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global 3D Bioprinting for Tissue and Organ Regeneration Market Size Market Share by Type (2017-2022)
- 2.4 3D Bioprinting for Tissue and Organ Regeneration Segment by Application
- 2.4.1 Clinical Applications
- 2.4.2 Research Applications
- 2.4.3 Drug and Medical Research
- 2.4.4 Others
- 2.5 3D Bioprinting for Tissue and Organ Regeneration Market Size by Application
- 2.5.1 3D Bioprinting for Tissue and Organ Regeneration Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global 3D Bioprinting for Tissue and Organ Regeneration Market Size Market Share by Application (2017-2022)
3 3D Bioprinting for Tissue and Organ Regeneration Market Size by Player
- 3.1 3D Bioprinting for Tissue and Organ Regeneration Market Size Market Share by Players
- 3.1.1 Global 3D Bioprinting for Tissue and Organ Regeneration Revenue by Players (2020-2022)
- 3.1.2 Global 3D Bioprinting for Tissue and Organ Regeneration Revenue Market Share by Players (2020-2022)
- 3.2 Global 3D Bioprinting for Tissue and Organ Regeneration Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 3D Bioprinting for Tissue and Organ Regeneration by Regions
- 4.1 3D Bioprinting for Tissue and Organ Regeneration Market Size by Regions (2017-2022)
- 4.2 Americas 3D Bioprinting for Tissue and Organ Regeneration Market Size Growth (2017-2022)
- 4.3 APAC 3D Bioprinting for Tissue and Organ Regeneration Market Size Growth (2017-2022)
- 4.4 Europe 3D Bioprinting for Tissue and Organ Regeneration Market Size Growth (2017-2022)
- 4.5 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas 3D Bioprinting for Tissue and Organ Regeneration Market Size by Country (2017-2022)
- 5.2 Americas 3D Bioprinting for Tissue and Organ Regeneration Market Size by Type (2017-2022)
- 5.3 Americas 3D Bioprinting for Tissue and Organ Regeneration Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC 3D Bioprinting for Tissue and Organ Regeneration Market Size by Region (2017-2022)
- 6.2 APAC 3D Bioprinting for Tissue and Organ Regeneration Market Size by Type (2017-2022)
- 6.3 APAC 3D Bioprinting for Tissue and Organ Regeneration Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe 3D Bioprinting for Tissue and Organ Regeneration by Country (2017-2022)
- 7.2 Europe 3D Bioprinting for Tissue and Organ Regeneration Market Size by Type (2017-2022)
- 7.3 Europe 3D Bioprinting for Tissue and Organ Regeneration Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration by Region (2017-2022)
- 8.2 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market Size by Type (2017-2022)
- 8.3 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.1 Global 3D Bioprinting for Tissue and Organ Regeneration Forecast by Regions (2023-2028)
- 10.1.1 Global 3D Bioprinting for Tissue and Organ Regeneration Forecast by Regions (2023-2028)
- 10.1.2 Americas 3D Bioprinting for Tissue and Organ Regeneration Forecast
- 10.1.3 APAC 3D Bioprinting for Tissue and Organ Regeneration Forecast
- 10.1.4 Europe 3D Bioprinting for Tissue and Organ Regeneration Forecast
- 10.1.5 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Forecast
- 10.2 Americas 3D Bioprinting for Tissue and Organ Regeneration Forecast by Country (2023-2028)
- 10.2.1 United States 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.2.2 Canada 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.2.3 Mexico 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.2.4 Brazil 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.3 APAC 3D Bioprinting for Tissue and Organ Regeneration Forecast by Region (2023-2028)
- 10.3.1 China 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.3.2 Japan 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.3.3 Korea 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.3.4 Southeast Asia 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.3.5 India 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.3.6 Australia 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.4 Europe 3D Bioprinting for Tissue and Organ Regeneration Forecast by Country (2023-2028)
- 10.4.1 Germany 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.4.2 France 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.4.3 UK 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.4.4 Italy 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.4.5 Russia 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.5 Middle East & Africa 3D Bioprinting for Tissue and Organ Regeneration Forecast by Region (2023-2028)
- 10.5.1 Egypt 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.5.2 South Africa 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.5.3 Israel 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.5.4 Turkey 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.5.5 GCC Countries 3D Bioprinting for Tissue and Organ Regeneration Market Forecast
- 10.6 Global 3D Bioprinting for Tissue and Organ Regeneration Forecast by Type (2023-2028)
- 10.7 Global 3D Bioprinting for Tissue and Organ Regeneration Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 BIOLIFE4D
- 11.1.1 BIOLIFE4D Company Information
- 11.1.2 BIOLIFE4D 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.1.3 BIOLIFE4D 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 BIOLIFE4D Main Business Overview
- 11.1.5 BIOLIFE4D Latest Developments
- 11.2 Organovo
- 11.2.1 Organovo Company Information
- 11.2.2 Organovo 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.2.3 Organovo 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Organovo Main Business Overview
- 11.2.5 Organovo Latest Developments
- 11.3 Celllink
- 11.3.1 Celllink Company Information
- 11.3.2 Celllink 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.3.3 Celllink 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Celllink Main Business Overview
- 11.3.5 Celllink Latest Developments
- 11.4 Aspect Biosystems
- 11.4.1 Aspect Biosystems Company Information
- 11.4.2 Aspect Biosystems 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.4.3 Aspect Biosystems 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Aspect Biosystems Main Business Overview
- 11.4.5 Aspect Biosystems Latest Developments
- 11.5 Cyfuse Biomedical
- 11.5.1 Cyfuse Biomedical Company Information
- 11.5.2 Cyfuse Biomedical 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.5.3 Cyfuse Biomedical 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Cyfuse Biomedical Main Business Overview
- 11.5.5 Cyfuse Biomedical Latest Developments
- 11.6 TeVido Biodevices
- 11.6.1 TeVido Biodevices Company Information
- 11.6.2 TeVido Biodevices 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.6.3 TeVido Biodevices 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 TeVido Biodevices Main Business Overview
- 11.6.5 TeVido Biodevices Latest Developments
- 11.7 Digilab
- 11.7.1 Digilab Company Information
- 11.7.2 Digilab 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.7.3 Digilab 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Digilab Main Business Overview
- 11.7.5 Digilab Latest Developments
- 11.8 Advanced Solutions Life Sciences
- 11.8.1 Advanced Solutions Life Sciences Company Information
- 11.8.2 Advanced Solutions Life Sciences 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.8.3 Advanced Solutions Life Sciences 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Advanced Solutions Life Sciences Main Business Overview
- 11.8.5 Advanced Solutions Life Sciences Latest Developments
- 11.9 TRS – Tissue Regeneration Systems
- 11.9.1 TRS – Tissue Regeneration Systems Company Information
- 11.9.2 TRS – Tissue Regeneration Systems 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.9.3 TRS – Tissue Regeneration Systems 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 TRS – Tissue Regeneration Systems Main Business Overview
- 11.9.5 TRS – Tissue Regeneration Systems Latest Developments
- 11.10 Nscrypt, Inc
- 11.10.1 Nscrypt, Inc Company Information
- 11.10.2 Nscrypt, Inc 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.10.3 Nscrypt, Inc 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Nscrypt, Inc Main Business Overview
- 11.10.5 Nscrypt, Inc Latest Developments
- 11.11 EnvisionTEC
- 11.11.1 EnvisionTEC Company Information
- 11.11.2 EnvisionTEC 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.11.3 EnvisionTEC 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 EnvisionTEC Main Business Overview
- 11.11.5 EnvisionTEC Latest Developments
- 11.12 MedPrin
- 11.12.1 MedPrin Company Information
- 11.12.2 MedPrin 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.12.3 MedPrin 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 MedPrin Main Business Overview
- 11.12.5 MedPrin Latest Developments
- 11.13 Nano3D Sciences
- 11.13.1 Nano3D Sciences Company Information
- 11.13.2 Nano3D Sciences 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.13.3 Nano3D Sciences 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Nano3D Sciences Main Business Overview
- 11.13.5 Nano3D Sciences Latest Developments
- 11.14 Rokit
- 11.14.1 Rokit Company Information
- 11.14.2 Rokit 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.14.3 Rokit 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Rokit Main Business Overview
- 11.14.5 Rokit Latest Developments
- 11.15 Cellbricks
- 11.15.1 Cellbricks Company Information
- 11.15.2 Cellbricks 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.15.3 Cellbricks 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Cellbricks Main Business Overview
- 11.15.5 Cellbricks Latest Developments
- 11.16 REGEMAT 3D
- 11.16.1 REGEMAT 3D Company Information
- 11.16.2 REGEMAT 3D 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.16.3 REGEMAT 3D 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 REGEMAT 3D Main Business Overview
- 11.16.5 REGEMAT 3D Latest Developments
- 11.17 Allevi
- 11.17.1 Allevi Company Information
- 11.17.2 Allevi 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.17.3 Allevi 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Allevi Main Business Overview
- 11.17.5 Allevi Latest Developments
- 11.18 Poietis
- 11.18.1 Poietis Company Information
- 11.18.2 Poietis 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.18.3 Poietis 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Poietis Main Business Overview
- 11.18.5 Poietis Latest Developments
- 11.19 T&R BIOFAB
- 11.19.1 T&R BIOFAB Company Information
- 11.19.2 T&R BIOFAB 3D Bioprinting for Tissue and Organ Regeneration Product Offered
- 11.19.3 T&R BIOFAB 3D Bioprinting for Tissue and Organ Regeneration Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 T&R BIOFAB Main Business Overview
- 11.19.5 T&R BIOFAB Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on 3D Bioprinting for Tissue and Organ Regeneration. Industry analysis & Market Report on 3D Bioprinting for Tissue and Organ Regeneration is a syndicated market report, published as Global 3D Bioprinting for Tissue and Organ Regeneration Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of 3D Bioprinting for Tissue and Organ Regeneration market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
